Frontiers in Pharmacology

Original Research

Published on 05 Jun 2023

Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia

in Drugs Outcomes Research and Policies

Siew Chin Ong
Joo Zheng Low
Stephan Linden

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195124

4,300 views
5 citations

Editorial

Published on 05 Jun 2023

Editorial: Insights in inflammation pharmacology: 2022

in Inflammation Pharmacology

Paola Patrignani
Patrizia Ballerini
Per-Johan Jakobsson
Dieter Steinhilber

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1223761

1,290 views

Original Research

Published on 05 Jun 2023

Deciphering anti-infectious compounds from Peruvian medicinal Cordoncillos extract library through multiplexed assays and chemical profiling

in Ethnopharmacology

Pedro G. Vásquez-Ocmín
Sandrine Cojean
Vincent Roumy
Guillaume Marti
Sébastien Pomel
Alice Gadea
Karine Leblanc
Indira Dennemont
Liliana Ruiz-Vásquez
Hivelli Ricopa Cotrina

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100542

3,028 views

Original Research

Published on 05 Jun 2023

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir

in Pharmacology of Infectious Diseases

Jiantao Zheng
Wencong Hong
Chanjuan Zhou
Donghuang Hong
Hong Yan
Yanghui Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146938

2,628 views
1 citation

Original Research

Published on 05 Jun 2023

TMS-evoked potential in the dorsolateral prefrontal cortex to assess the severity of depression disease: a TMS-EEG study

in Neuropharmacology

Xingxing Li
Meng Chen
Qinqin Liu
Chao Zheng
Chang Yu
Guangwei Hou
Zan Chen
Yiqing Chen
Yinping Chen
Guidong Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207020

5,861 views
3 citations

Original Research

Published on 05 Jun 2023

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease

in Drugs Outcomes Research and Policies

Xiao Zou
Liang Wang
Sha-Sha Sun
Yi-Xin Hu
Hong-Wei Liu
Hao Wang
Jian Cao
Hong-Bin Liu
Li Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183839

1,867 views
1 citation

Original Research

Published on 05 Jun 2023

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system

in Pharmacoepidemiology

Zhihong Fang
Zhiqiang Xu
Wei Zhu
Mingming Yu
Chunmei Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101861

5,363 views
18 citations

Review

Published on 02 Jun 2023

Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease

in Pharmacology of Anti-Cancer Drugs

Fei Li
Pei-Feng Li
Xiao-Dan Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1173040

3,782 views
15 citations

Original Research

Published on 02 Jun 2023

Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Wenchao Lu
Huiyun Zhang
Qixiang Guo
Zhuoyue Gou
Jiannan Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076473

3,534 views
6 citations

Original Research

Published on 02 Jun 2023

Influencing factors of medication literacy among community-dwelling older adult patients with hypertension: a study based on social learning theory

in Drugs Outcomes Research and Policies

Tingting Lu
Zhen Yang
Ping Chen
Jingyan Li
Chen Zheng
Linghui Kong
Huijun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184701

4,143 views
3 citations

Review

Published on 02 Jun 2023

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

in Inflammation Pharmacology

Daniela Melchiorri
Sara Merlo
Benjamin Micallef
John-Joseph Borg
František Dráfi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1196413

16,487 views
28 citations

Original Research

Published on 02 Jun 2023

Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study

in Respiratory Pharmacology

Libor Fila
Alzbeta Grandcourtova
Alena Bilkova
Pavel Drevinek

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178009

1,926 views
1 citation

Review

Published on 02 Jun 2023

Recent advances of exosomes in age-related macular degeneration

in Integrative and Regenerative Pharmacology

Feng Gu
Jiyu Jiang
Peng Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1204351

4,714 views
7 citations

Systematic Review

Published on 02 Jun 2023

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis

in Obstetric and Pediatric Pharmacology

Kai Chen
Xiaoxia Liu
Xianhua Meng
Hui Li
Chenchen Yang
Xiaohong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138968

2,817 views
1 citation

Editorial

Published on 02 Jun 2023

Editorial: Neurovascular dysfunction after brain injury

in Neuropharmacology

Chongjie Cheng
Lei Huang
Zongduo Guo
Tunan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222328

3,023 views
1 citation

Original Research

Published on 02 Jun 2023

BuShen HuoXue decoction improves fertility through intestinal hsp-16.2-mediated heat-shock signaling pathway in Caenorhabditis elegans

in Ethnopharmacology

Kanglu Wu
Xudong Zhao
Xian Xiao
Miao Chen
Liang Wu
Chao Jiang
Jing Jin
Lei Li
Qinli Ruan
Jun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210701

2,957 views
2 citations